| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Nutex Health Inc. Common Stock$147.23
-2.94 (-1.96%)
Market Cap
704.15 M
EPS
10.74
P/E Ratio
10.4 $
Value Trade
19.02 M
SEC Financials
Q1 2026Dilution Risk
Revenue
216.49 M
Operating CF
75.52 M
Total Assets
957.32 M
Total Liabilities
515.26 M
Equity
346.29 M
D/E Ratio
12,345
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
207.35 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
Apr 30, 2026
Overview
Volume
98.95 K
52 Week Range
77.21 - 193.07
% held by Insiders
32.67 %
% held by Institutions
41.39 %
Enterprise Value
963.66 M
Total Shares
6.88 M
Short %
24.34 %
Float Shares
4.38 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in NUTX
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
Nutex Health Inc. Common Stock (NUTX) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
NUTX
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
NUTX
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
NUTX
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
NUTX Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
NUTX Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-NUTX
Apr 30, 2026Document NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS HOUSTON, TX (PRNewswire) - APRIL 30, 2026 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ NUTX), today announced financial results for the
Nutex Health Inc. reported its financial results for the first quarter of 2026, highlighting a revenue increase of 2.2% year-over-year to $216.5 million, driven mainly by growth in its hospital division. The company's net income attributable to shareholders surged by 120.6% to $46.8 million, reflecting effective operational strategies and cash generation. Nutex Health is also seeing an increase in total visits, and it plans to open three new hospital facilities this year, aiming for sustained growth.
Read more →-NUTX
Apr 22, 2026Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call
Nutex Health, Inc. plans to release its first quarter financial results for 2026 on April 30, 2026, followed by a conference call on May 1, 2026, at 9:30 a.m. CT. The call will provide insights into the company's financial performance and business updates. Nutex operates a network of micro hospitals and physician groups across 12 states.
Read more →-NUTX
Mar 5, 2026Document NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM FULL YEAR 2025 HIGHLIGHTS Total revenue of $875.3 million for the year 2025 versus $479.9 million for the year 2024, an i
Nutex Health announced significant financial results for 2025, reporting total revenue of $875.3 million, up 82.4% from 2024, and net income of $70.8 million. Key highlights include a diluted EPS increase to $10.48 and a substantial rise in adjusted EBITDA to $259.6 million, reflecting strong operational growth. However, the company faced challenges in Q4 2025, with a revenue decline of 41.1%, attributed mainly to arbitration-related adjustments. CEO Tom Vo emphasized the firm's robust growth strategy and the opening of new facilities, alongside corrective measures for previously disclosed financial control weaknesses.
Read more →-NUTX
Nov 19, 2025Document NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024,
Nutex Health reported exceptional financial results for the third quarter and year-to-date ending September 30, 2025. The company achieved total revenue of $723.6 million for the first nine months, a remarkable increase of 225.5% compared to the prior year. Net income turned from a loss of $9.5 million to a profit of $59.0 million, showcasing a substantial operational improvement. Notably, adjusted EBITDA surged to $243.0 million, indicating strong profitability amidst robust growth in its micro hospital and outpatient services.
Read more →-NUTX
Nov 18, 2025Document NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS Total revenue of $455.8 million for the first half of 2025 versus $143.5 million for the first half of 2024, an increase of 21
Nutex Health reported significant financial growth for the first half of 2025, with total revenue increasing by 217.5% to $455.8 million. The company flipped from a net loss in the prior year to a net income of $3.5 million, while EBITDA also saw substantial growth. Despite high stock-based compensation expenses and a quarterly net loss attributed to these costs, Nutex announced a stock repurchase program to boost shareholder confidence. The financial results reflect a strong recovery and ongoing growth strategy in the healthcare sector.
Read more →-NUTX
Nov 18, 2025Document NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS Total revenue of $211.8 million for Q1 2025 versus $67.5 million for Q1 2024, an increase of 214.0% Net income attributable to Nutex Health Inc.
Nutex Health Inc. reported substantial financial growth for Q1 2025, with a revenue increase to $211.8 million from $67.5 million in Q1 2024. The net income for the period reached $21.2 million, marking a recovery from a net loss of $0.4 million the previous year. Adjusted EBITDA also saw significant gains, moving from a loss to $72.8 million. The company cited successful arbitration efforts with insurance carriers as contributing factors to its improved financial metrics.
Read more →-NUTX
Nov 18, 2025Document NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS FULL YEAR 2024 HIGHLIGHTS Total revenue of $479.9 million for the year 2024 versus $247.6 million for the year 2023, an increase of 93.8% Net income attributa
Nutex Health reported restated financial results for the year 2024, revealing significant growth with total revenue up 93.8% to $479.9 million and net income of $52.1 million, recovering from a loss in the prior year. The adjustments included reclassifications in financial statements, resulting in a slight increase in liabilities and a small decrease in equity. Notably, EBITDA and adjusted EBITDA showed marked improvements, reinforcing the company's financial strength, despite the challenges posed by a substantial increase in stock-based compensation expenses. The company expresses confidence in its growth strategy and plans to utilize a stock repurchase program to enhance shareholder returns.
Read more →-NUTX
Sep 30, 2025Document NUTEX HEALTH PROVIDES CORPORATE UPDATE Significant Year-over-Year Growth in Patient Volume and Cash Collections HOUSTON, TX (PRNewswire) - OCTOBER 20, 2025 - Nutex Health Inc. ("Nutex Health" or the "Company") (
Nutex Health Inc. reported a substantial increase in both patient volume and cash collections for the third quarter of 2025, marking a growth of 11.1% and 258.8%, respectively, compared to the same quarter in 2024. The company attributes this growth to strategic expansions and an improved revenue cycle management. However, Nutex is currently facing challenges due to errors in previously issued financial statements that have led to delays in filing required reports with Nasdaq. The company has submitted a plan to regain compliance and is working to finalize its financial documentation.
Read more →-NUTX
Sep 22, 2025Forward-Looking Statements Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. When used i
Nutex Health Inc. has announced the appointment of Wesley Bamburg as its new Chief Operating Officer, effective October 13, 2025. Bamburg brings 20 years of experience in healthcare operations and has previously held COO positions at HCA Healthcare facilities. His leadership is expected to enhance Nutex Health's operations and contribute to the company's ongoing growth and commitment to patient-centered care. The announcement reflects the company's strategy to strengthen its leadership as it expands its healthcare delivery model across the U.S.
Read more →-NUTX
May 13, 2025NUTEX HEALTH reports FIRST quarter 2025 financial results Total revenue of $211.8 million Versus $67.5 Million IN q1 2024, an increase of 213.8% NET INCOME ATTRIBUTABLE TO nUTEX hEALTH iNC. OF $14.6 MILLION VERSUS Net LO
Nutex Health Inc. has reported impressive first-quarter financial results for 2025, showcasing a revenue increase of 213.8% to $211.8 million compared to the same period last year. The company also achieved a net income of $14.6 million, indicating a significant turnaround from a loss in the previous year. Key performance indicators highlight strong operational efficiency, with gross profit margins reaching a record high. Nutex Health attributes this success to improved operational strategies and a focus on patient care, positioning itself favorably for continued growth.
Read more →-NUTX
Mar 31, 2025NUTEX HEALTH reports FOURTH quarter and FULL year 2024 financial results Full year 2024 highlights: Total revenue of $479.9 million Versus $247.6 Million IN 2023, an increase of 93.8% NET INCOME OF $52.2 MILLION VERSUS N
Nutex Health Inc. has reported strong financial results for the fourth quarter and full year 2024, showcasing a 93.8% increase in total revenue compared to 2023. The company achieved a net income of $52.2 million, significantly improving upon the previous year’s losses. Operational improvements, including a 16.9% increase in hospital visits, were highlighted, driven in part by a successful arbitration initiative. As Nutex Health prepares for 2025, it aims to maintain its momentum and optimize operational efficiency.
Read more →-NUTX
Feb 5, 2025Nutex Health Issues No Surprises Act (NSA) Arbitration Update HOUSTON
Nutex Health Inc. provided an update on its participation in the arbitration process outlined in the No Surprises Act. The company reports a high success rate of over 80% in arbitration, enabling substantial recovery of previously underpaid claims. However, Nutex acknowledges the inherent costs of arbitration and uncertainties about future successes and regulatory changes that could impact its operations. The firm remains committed to optimizing its healthcare delivery model, despite the risks involved.
Read more →-NUTX
Nov 7, 2024NUTEX HEALTH reports third quarter and year to date
Nutex Health Inc. reported strong third-quarter financial results for 2024, showcasing a 25% revenue growth and a significant increase in gross profit. The company's adjusted EBITDA reached $13.5 million, highlighting enhanced profitability during the period. Despite these positive developments, Nutex reported a net loss of $8.79 million and faces an accumulating deficit. The management remains optimistic about sustaining growth and improving cash flow as they continue expanding their hospital and health divisions.
Read more →-NUTX
Aug 8, 2024NUTEX HEALTH reports SECOND quarter and Six months ended
Nutex Health Inc. reported strong financial performance for the second quarter and first half of 2024, highlighting a 29% increase in revenue and significant growth in operating income. The company's CFO noted a continued focus on top-line growth and improving profitability. However, the report also indicated a net loss attributable to Nutex Health, alongside an increase in accumulated deficits and impairments. The company remains optimistic about its strategic initiatives aimed at sustainable growth and enhancing shareholder value.
Read more →-NUTX
May 9, 2024NUTEX HEALTH reports FIRST quarter 2024 financial results Total revenue of $67.5 million for fIRST qUARTER 2024 vs $56.3 Million in 2023, an increase of 20% HOSPITAL DIVISION VISITS OF 40,068 FOR THE FIRST QUARTER 2024 V
Nutex Health Inc. (NUTX) reported a 20% increase in total revenue for the first quarter of 2024, amounting to $67.5 million, up from $56.3 million in the same period in 2023. The company's hospital division experienced a 119% increase in operating income, reaching $10.5 million. Despite these positive financial metrics, Nutex reported a net loss of $364,075. The company maintains a solid cash position, indicating ongoing growth potential and financial stability.
Read more →-NUTX
Mar 28, 2024NUTEX HEALTH reports fourth quarter and Full YEAR 2023 financial results Total revenue of $247.6 million for the year ended 2023 vs $219.3 Million in 2022, an increase of 13% hospital division operating income of $36.3 m
Nutex Health Inc. reported its financial results for the fourth quarter and full year of 2023, showcasing a year-over-year revenue increase of 13%, amounting to $247.6 million. The hospital division experienced a remarkable 142% rise in operating income, totaling $36.3 million. However, the company also revealed a net loss of $43.4 million for the year and an increased accumulated deficit. The management has initiated a strategic plan aimed at expense reduction and resource optimization to improve financial performance moving forward.
Read more →-NUTX
Jan 24, 2024RISK FACTORS As of the date of this Current Report, the Company updates and supplements the risk factors disclosed in its Annual Report on Form 10-K for the fiscal year ended
NUTX has updated its risk factors, highlighting critical financial challenges as it navigates operational losses and funding. The company may face difficulties in raising sufficient capital for its expansion plans, potentially necessitating equity offerings that could dilute current stockholders. Additionally, the closure of underperforming hospitals could lead to short-term revenue declines, and reimbursement changes for emergency services raise further uncertainties. This could have a significant adverse effect on the company's financial health and operational outlook.
Read more →-NUTX
Jan 11, 2024S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L C O N F I D E N T I A L 2 General The information contained in this Investor Presentation (“P
Nutex Health is focusing on long-term growth through the expansion of its micro-hospital facilities, with 22 locations opened in 2023 and plans for additional facilities in 2024 and 2025. The company aims to provide high-quality and cost-effective healthcare while leveraging its portfolio of coordinated assets. Recent financial reports indicate positive operating cash flow, and strategic plans include enhancing revenue cycle management due to regulatory challenges. Overall, Nutex Health is well-positioned within an attractive healthcare market but faces challenges linked to its financing and regulatory landscape.
Read more →-NUTX
Nov 9, 2023NUTEX HEALTH reports THIRd quarter 2023 financial results NET revenue of $62.7 million NET CASH FROM OPERATING ACTIVITIES OF $2.0 MILLION Company expects to open FIVE NEW MICRO-HOPITALS IN 2024 HOUSTON, TX (PRNewswire)
Nutex Health Inc. announced its financial results for the third quarter of 2023, reporting a net revenue of $62.7 million, marking a significant increase compared to the previous year. The company highlighted positive trends in operational cash flow and plans to expand by opening five new micro-hospitals in 2024. However, it also reported a net loss of $5.54 million during the quarter, alongside a considerable accumulated deficit. The company aims to continue executing its growth strategy while managing existing liabilities.
Read more →-NUTX
Aug 22, 2023NUTEX HEALTH ANNOUNCES THE ACQUISITION OF POPULATION HEALTH ASSOCIATES AND MANAGED CARE INSURANCE CONSULTANTS ACQUISITION EXPANDS COMPANY'S PRESENCE IN FLORIDA AND ADDS APPROXIMATELY 112 PRIMARY CARE PHYSICIANS AND 4400
Nutex Health Inc. has announced the acquisition of Population Health Associates and Managed Care Insurance Consultants, significantly expanding its operations in Florida. The deal will introduce approximately 112 primary care physicians and add about 4,400 managed care patients to its system. This acquisition aligns with Nutex's strategy of building integrated healthcare models and enhances its existing patient network. The company's plans for further expansion in Florida include the opening of 5-6 micro-hospitals by the end of 2025.
Read more →-NUTX
Aug 9, 2023NUTEX HEALTH reports Second quarter 2023 financial results NET revenue of $58.9 million Company expects to open 1-2 more hospitals in 2023 and another 14 by end of 2025 HOUSTON, TX (PRNewswire) - AUGUST 9, 2023 - Nutex H
Nutex Health Inc. announced its financial results for the second quarter of 2023, reporting a net revenue of $58.9 million and an adjusted EBITDA increase to $4.0 million. The company plans to open 1-2 additional hospitals in 2023 and is strategically expanding with new physician networks. However, Nutex reported a net loss of $3.5 million for the quarter, indicating challenges despite increased operational capacity. Overall, the company maintains a positive outlook for growth in patient volumes and service lines for the remainder of the year.
Read more →-NUTX
May 15, 2023NUTEX HEALTH reports FIRST quarter 2023 financial results NET revenue of $56.3 million Net cash from operating activities of $1.1 million Company expects to open 4-5 more hospitals in 2023 and another 14 by end of 2025 H
Nutex Health Inc. reported its financial results for the first quarter of 2023, showing a net revenue of $56.3 million, although it also experienced a net loss of $5.1 million. The company is planning to expand its operations by opening 4-5 additional micro hospitals this year, which reflects its growth strategy amid challenging market conditions. Nutex's balance sheet remains strong, with $32.8 million in cash, providing financial support for its growth initiatives.
Read more →-NUTX
Apr 11, 2023NUTEX HEALTH announces that it has entered into a $100 million pre-paid advance agreement with yorkville advisors global l.p. HOUSTON, TX (PRNewswire) - APRIL 11, 2023 - Nutex Health Inc. ("Nutex Health" or the "Company"
Nutex Health Inc. has announced a significant $100 million pre-paid advance agreement with Yorkville Advisors Global L.P. The financing will be used to support the company's growth initiatives, including expanding its healthcare footprint and facilitating opportunistic acquisitions. The agreement allows Nutex Health to draw advances based on certain conditions and is seen as a positive endorsement of its integrated, value-based healthcare model. Nutex operates multiple healthcare facilities across several states, emphasizing technology-enabled delivery systems.
Read more →-NUTX
Apr 5, 2023NUTEX HEALTH announces change to its board of directors HOUSTON, TX (PRNewswire) - APRIL 5, 2023 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated health
Nutex Health Inc. announced changes to its Board of Directors, with Dr. Matthew Young departing after a one-year term. Dr. Danniel Stites has been elected to the Board, bringing over 10 years of experience in emergency medicine and management roles at various healthcare facilities. The company expressed appreciation for Dr. Young's service and highlighted the valuable expertise Dr. Stites will contribute as it aims to grow its business.
Read more →-NUTX
Mar 2, 2023NUTEX HEALTH Inc. reports fourth quarter and Full YEAR 2022 financial results Total revenue of $219.3 million for the year ended 2022 Net cash from operating activities of $50.6 million for the YEAR ended 2022 Company ex
NUTEX HEALTH Inc. reported its fourth quarter and full year 2022 financial results, highlighting a total revenue of $219.3 million. Despite a challenging year marked by a non-cash goodwill impairment and lower patient visits, the company is focusing on strategic initiatives to enhance future performance. With plans to expand its facilities and grow its independent practice association, Nutex aims to improve its financial health in the coming years.
Read more →-NUTX
Feb 28, 2023Nutex Health Inc. Investor Presentation.
Nutex Health Inc. Investor Presentation.
Read more →-NUTX
Dec 21, 2022NUTEX HEALTH to present at the 41 st Annual J.P. Morgan Healthcare conference HOUSTON, TX (PRNewswire) - DECEMBER 21, 2022 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology
NUTEX HEALTH to present at the 41st Annual J.P. Morgan Healthcare conference HOUSTON, TX (PRNewswire) - DECEMBER 21, 2022 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised
Read more →-NUTX
Nov 22, 2022NUTEX HEALTH reports THIRD quarter 2022 financial results and announces Common stock purchase agreement for a commitment to purchase up to $100 million worth of shares of its common stock with lincoln park capital Net ca
HEALTH reports THIRD quarter 2022 financial results and announces stock purchase agreement for a commitment to purchase up to $100 million worth of shares of its common stock with - Net cash from operating activities of $46.1 million for the nine months ended September 30, 2022
Read more →-NUTX
Oct 10, 2022NUTEX HEALTH PROVIDES CORPORATE UPDATE HOUSTON, TX (PRNewswire)
HEALTH PROVIDES CORPORATE UPDATE TX (PRNewswire) - October 10, 2022 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, healthcare management and operations company comprised of 21 micro hospitals in 8 states and primary care-centric, risk-be
Read more →-NUTX
Aug 22, 2022NUTEX HEALTH reports secONd quarter 2022 financial results EBITDA of $5.4 million for the second quarter of 2022 adjusted ebitda of $9.4 million for the second quarter of 2022 NET loss of $19.4 MILLION FOR THE SECOND QUA
HEALTH reports secONd quarter 2022 financial results TX (PRNewswire) - AUGUST 22, 2022 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospital
Read more →-NUTX
Jun 16, 2022to this filing for a detailed description of the revisions as of and for the year ended
HEALTH HOLDCO SUPPLEMENTAL INFORMATION Health Inc. ("Nutex Health" or the "Company"), is a physician-led, technology-enabled healthcare services company comprised of its wholly owned subsidiary Nutex Health Holdco, LLC , with the 21 hospital facilities in eight states (hospital
Read more →-NUTX
Jun 10, 2022Nutex health announces the appointment of jon bates as its new CHIEF FINANCIAL OFFICER HOUSTON, TX (PRNewswire)
health announces the appointment of jon bates as its new CHIEF FINANCIAL OFFICER TX (PRNewswire) - June 10, 2022 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled healthcare services company comprised of a hospital divisio
Read more →-NUTX
Apr 1, 2022CLINIGENCE HOLDINGS and nutex health announce completion of merger and listing on the nasdaq capital market FT. LAUDERDALE, FL and HOUSTON, TX (PRNewswire)
HOLDINGS and nutex health announce completion of merger and listing on the nasdaq capital market FL and HOUSTON, TX (PRNewswire) - April 1, 2022 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: CLNH), a primary care-centric, technology-enabled, risk-bearing pop
Read more →-NUTX
Mar 17, 2022CLINIGENCE HOLDINGS ANNOUNCES RESULTS OF 2022 SPECIAL MEETING OF STOCKHOLDERS FT. LAUDERDALE, FL (PRNewswire) - MARCH 16, 2022 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC:CLNH), a leading technology-
HOLDINGS ANNOUNCES RESULTS OF 2022 SPECIAL MEETING OF STOCKHOLDERS LAUDERDALE, FL (PRNewswire) - MARCH 16, 2022 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC:CLNH), a leading technology-enabled, risk-bearing population health management company, today announc
Read more →-NUTX
Nov 23, 2021AGREEMENT AND PLAN OF MERGER BY AND AMONG NUTEX HEALTH HOLDCO LLC, CLINIGENCE HOLDINGS, INC., NUTEX ACQUISITION LLC, MICRO HOSPITAL HOLDING LLC (SOLELY FOR THE PURPOSES OF CERTAIN SECTIONS OF ARTICLE IV, SECTION 12.15
HOSPITAL HOLDING LLC (SOLELY FOR THE PURPOSES OF CERTAIN SECTIONS OF ARTICLE IV, SECTION 12.15 AND THE SECTIONS RELATED THERETO), HEALTH LLC (SOLELY FOR THE PURPOSES OF SECTION 4.18 AND THE SECTIONS RELATED THERETO) T. VO, IN HIS CAPACITY AS THE NUTEX REPRESENTATIVE AS OF NOVE
Read more →-NUTX
Oct 21, 2021CLINIGENCE HOLDINGS announces the acquisition of procare health FT. LAUDERDALE, FL (PRNewswire)
HOLDINGS announces the acquisition of procare health LAUDERDALE, FL (PRNewswire) - October 21, 2021 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: CLNH), one of the nation's leading technology-enabled, risk-bearing population health management companies, tod
Read more →-NUTX
May 21, 2021CLINIGENCE HOLDINGS announces the SIGNING OF A BINDING LETTER OF INTENT TO ACQUIRE PROCARE HEALTH FT. LAUDERDALE, FL (PRNewswire)
HOLDINGS announces the SIGNING OF A BINDING LETTER OF INTENT ACQUIRE PROCARE HEALTH LAUDERDALE, FL (PRNewswire) - May 21, 2021 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: CLNH), one of the nation's leading technology-enabled, risk-bearing population healt
Read more →-NUTX
Mar 2, 2021CLINIGENCE HOLDINGS announces the successful acquisitions of accountable healthcare america, inc. and AHP Management, inc. to form one of the nation's leading technology-enabled population health management companies ATL
HOLDINGS announces the successful acquisitions of healthcare america, inc. and AHP Management, inc. to form one of the leading technology-enabled population health management companies GA (PRNewswire) - March 2, 2021 - Clinigence Holdings, Inc. ("Clinigence" or the "Company")
Read more →-NUTX
Jul 15, 2020clinigence holdings provides strategic update ATLANTA, GA (BUSINESSWIRE)
holdings provides strategic update GA (BUSINESSWIRE) - July 15, 2020 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: CLNH), a pioneer in clinical data integration, clinical quality reporting and population health analytics, today is providing an update to its
Read more →-NUTX
Jun 27, 2020From: Mark Fawcett Sent: Saturday
June 27, 2020 6:16 PM am resigning from the Board effective immediately. activities helping to raise capital for my Board role with Apollo, and my full time job leave me little time for anything else. I think the remaining Board has the skill and experience to bring the compan
Read more →-NUTX
Jun 3, 2020clinigence holdings and accountable healthcare america provide new update to shareholders ATLANTA, GA and FT. LAUDERDALE, FL (BUSINESSWIRE)
holdings and accountable healthcare america provide new update GA and FT. LAUDERDALE, FL (BUSINESSWIRE) - June 3, 2020 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: CLNH), a pioneer in clinical data integration, clinical quality reporting and population heal
Read more →-NUTX
May 16, 2020Lawrence Schimmel, M.D., FACS
Schimmel, M.D., FACS Hosseinion, Chairman Ivan Allen Jr. Blvd., Suite 875 follow-up to our recent conversation; due to outside obligations, I will no longer be able to serve as a member of the Board of Directors of Clinigence Holdings, Inc. effective today May 16, 2020. Schi
Read more →-NUTX
Nov 12, 2019CLINIGENCE HOLDINGS and accountable healthcare america sign letter of intent to merge ATLANTA, GA and FT. LAUDERDALE, FL (BUSINESSWIRE)
HOLDINGS and accountable healthcare america sign letter of intent to merge GA and FT. LAUDERDALE, FL (BUSINESSWIRE) - November 12, 2019 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: IGMBD), a pioneer in clinical data integration, clinical quality reporting a
Read more →-NUTX
Oct 31, 2019CLINIGENCE HOLDINGS, INC. GOES PUBLIC VIA A REVERSE MERGER WITH IGAMBIT, INC. ATLANTA, GA (BUSINESSWIRE)
HOLDINGS, INC. GOES PUBLIC VIA A REVERSE MERGER WITH IGAMBIT, INC. GA (BUSINESSWIRE) - October 31, 2019 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") announced today that it has become a publicly-traded company via a reverse merger with iGambit, Inc. ("iGambit")
Read more →-NUTX
Aug 9, 2019iGambit and clinigence holdings announce transformational merger SMITHTOWN, NY AND ATLANTA, GA (GLOBE NEWSWIRE)
and clinigence holdings announce transformational merger NY AND ATLANTA, GA (GLOBE NEWSWIRE) - August 9, 2019 - iGambit, Inc. ("iGambit" or "the Company") (OTC: IGMB), a fully reporting publicly-held company that wholly owns HealthDatix, a healthcare technology company with a
Read more →-NUTX
Jun 27, 2019iGambit Inc. and Clinigence Holdings Inc. sign Letter of Intent for Merger SMITHTOWN, N.Y.
Inc. and Clinigence Holdings Inc. sign Letter of Intent for Merger N.Y., June 27, 2019 (Globe Newswire) iGambit, Inc. (OTCMKTS: IGMB) is pleased to announce that it has entered into a Letter of Intent ("LOI") with Clinigence Holdings Inc. ("Clinigence") merger with Clinigence
Read more →-NUTX
Sep 7, 2018John Salerno, Chairman AMENDMENT #1 LETTER OF INTENT TO PURCHASE Personal and Confidential To: Winpoint Health LLC Date
#1 LETTER OF INTENT TO PURCHASE Amendment to the Letter of Intent refer to the Letter of Intent ("LOI") between the iGambit Inc. ("IGI") and Winpoint Health Inc. ( Winpoint" or "Company") and together referred to as ("Parties") dated June 14, 2018 ("Letter of Intent") with re
Read more →-NUTX
Jun 19, 2018Winpoint Health LLC and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire Winpoint Health
Health LLC and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire Winpoint Health LLC N.Y., June 19, 2018 (Globe Newswire) iGambit, Inc. (OTCBB: IGMB) is pleased to announce that it has entered into a Letter of Intent ("LOI") with Winpoint Health LLC. acquisition o
Read more →-NUTX
Jul 26, 2017During the past several months some significant events have occurred at iGambit.
To our Shareholders, Recent Company Events During the past several months some significant events have occurred at iGambit. On February 14, 2017 we acquired HubCentrix, Inc. (HubCentrix) and on April 6, 2017 we acquired the assets of the CyberCare Health Network Division from E
Read more →-NUTX
Jul 5, 2017Converted by EDGARwiz IGAMBIT Announces Sale of ARCMAIL TECHNOLOGIES and $6,000,000 liabilities reduction from Balance Sheet Press Release : iGambit Inc. - Friday
ARCMAIL TECHNOLOGIES and $6,000,000 liabilities reduction from Balance Sheet Press Release: iGambit Inc. - Friday, July 5, 2017 2PM EST SMITHTOWN, NY, July 5, 2017 Marketwire/ -- iGambit Inc. (OTCQB: IGMB), announced that on June 29, 2017 it completed the sale of its wholly o
Read more →-NUTX
May 8, 2017Converted by EDGARwiz IGAMBIT Announces Dr. Benedict S Maniscalco joins its Advisory Board. Press Release : iGambit Inc. Monday
IGAMBIT Announces Dr. Benedict S Maniscalco joins its Advisory Board. Press Release: iGambit Inc. Monday May 8, 2017 3:30PM EST SMITHTOWN, NY, May 8, 2017 Marketwire/ -- iGambit Inc. (OTCQB: IGMB), announced that Dr. Benedict S Maniscalco has joined its Senior Advisory Board.
Read more →-NUTX
Apr 6, 2017Converted by EDGARwiz IGAMBIT Announces Acquisition of CyberCare Health Network, Inc. Press Release: iGambit Inc. Thursday
IGAMBIT Announces Acquisition of CyberCare Health Network, Inc. Press Release: iGambit Inc. Thursday, April 6, 2017 2:30PM SMITHTOWN, NY, April 7, 2017 Marketwired -- iGambit Inc. (OTCQB: IGMB), announced that on April 6, 2017 it acquired the CyberCare Health Network Divisio
Read more →-NUTX
Feb 15, 2017Converted by EDGARwiz IGAMBIT Announces Acquisition of HUBCENTRIX INC. A Leading Provider of Healthcare Technology Press Release : iGambit Inc. Wednesday
IGAMBIT Announces Acquisition of A Leading Provider of Healthcare Technology Press Release: iGambit Inc. Wednesday, February 15, 2017 2PM EST SMITHTOWN, NY, February 15, 2017 Marketwire/ -- iGambit Inc. (OTCQB: IGMB), announced that on February 14, 2017 it acquired HubCentri
Read more →-NUTX
Aug 26, 2016Converted by EDGARwiz HubCentrix Inc. and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire the assets of HubCentrix Inc. Smithtown, NY (Marketwired
HubCentrix Inc. and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire the assets of HubCentrix Inc. Smithtown, NY (Marketwired - August 26, 2016), HubCentrix and iGambit Inc.(OTCQB:IGMB) sign LOI . Under the terms of the LOI, iGambit Inc. will acquire substantial
Read more →-NUTX
Aug 15, 2016Converted by EDGARwiz EncounterCare and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire certain assets of CyberCare Health Network Inc. Smithtown, NY. (Marketwired - August 15 th , 2016 ), iG
EncounterCare and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire certain assets of CyberCare Smithtown, NY. (Marketwired - August 15th, 2016), iGambit Inc. (OTCQB:IGMB) iGambit Inc. announced it has entered into a LOI with EncounterCare Solutions Inc. (ECSL).
Read more →-NUTX
Nov 11, 2015Converted by EDGARwiz IGAMBIT Announces Sale of Gotham Subsidiary Press Release : iGambit Inc. - Tuesday
IGAMBIT Announces Sale of Gotham Press Release: iGambit Inc. - Tuesday November 11, 2015 2 PM EST SMITHTOWN, NY., November 11, 2015 Marketwire/ -- iGambit Inc. (OTCQB: IGMB), a diversified holding company, announced that on November 5, 2015, through its wholly owned subsidiar
Read more →-NUTX
May 13, 2015Converted by EDGARwiz IGAMBIT Files, Form 8-K Announces Execution of Letter of Intent to Acquire United Fertility Centers of America Press Release : iGambit Inc. Wed
IGAMBIT Files, Form 8-K Announces Execution of Letter of Intent to Acquire United Fertility Centers of America Press Release: iGambit Inc. Wed, May 13, 2015 2 PM EST SMITHTOWN, NY., May 13, 2015 /Marketwire/ -- iGambit Inc. (OTCQB: IGMB), a diversified holding company, annou
Read more →-NUTX
Apr 26, 2013LETTER OF RESIGNATION JOHN WATERS Converted by EDGARwiz
LETTER OF RESIGNATION JOHN WATERS Converted by EDGARwiz
Read more →-NUTX
Dec 31, 2012ON ACQUISITION Converted by EDGARwiz iGAMBIT Acquires Assets and Operations of IGX-GLOBAL Acquired Operations expected to show revenue of $39 million for the year ending
iGAMBIT Acquires Assets and Operations of Acquired Operations expected to show revenue of $39 million for the year ending December 31, 2012 Press Release: iGambit Inc Mon, Jan 7, 2013 12 PM EST SMITHTOWN, NY., Jan. 7, 2013 /PRNewswire/ -- iGAMBIT, Inc. (OTCQB: IGMB), a diver
Read more →-NUTX
Apr 4, 2012SOURCE: iGambit Inc.
SOURCE: iGambit Inc. April 4, 2012 2:00 PM ET iGambit Inc. Reports more than 100% Increase in 2011 Revenue SMITHTOWN, NY-(Marketwire-April 3, 2012) - iGambit Inc. (OTCBB: IGMB), a diversified technology development and holding company reported results for the year ended Decemb
Read more →Competitive Position
How NUTX ranks across every disease it competes inCompetitive Position is a premium feature
See how NUTX ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial